Clinical Trial Update: A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating varenicline to prevent relapse to smoking in patients with schizophrenia or bipolar disorder; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia
• Smoking

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2015-05-21